Endo Claims Teva, Others Infringe Uncrushable Opana IP
Endo Pharmaceuticals Inc. on Wednesday targeted Teva Pharmaceuticals Industries Inc., Par Pharmaceutical Inc., Mallinckrodt LLC and others with patent infringement lawsuits in New York aimed at blocking generic drugs that would...To view the full article, register now.
Already a subscriber? Click here to view full article